Feeds:
Posts
Comments

Archive for December, 2009

A solid group of experienced pharma marketing and e-healthcare folks contributed chapters to this e-book, called Best Strategic Learning Investment in 2010 (your investment: a bit of time – the download is free!)

If you’re wondering how best to approach the on-line world of patient advocacy, communities, and social media, here’s your starting point.

Contributors include:

Ellen Hoenig Carlson, Consultant, AdvanceMarketWoRx (editor) (thanks, Ellen!)

Marsha Shenk, Business Anthropologist, BestWork

Dave deBronkart, ePatient advocate/blogger

Andrew Spong, PhD, Consultant, STweM

Steve Woodruff, Consultant, Impactiviti

Susannah Fox, Health Researcher, Pew

Jonathan Richman, Strategic Planning, Bridge Worldwide

Adam Cohen, Partner, Rosetta

Wendy Blackburn, EVP, InTouch Solutions

Phil Baumann, RN, Consultant, CareVocate

Fard Johnmar, Consultant, Path of the Blue Eye project

John Mack, Publisher, Pharma Marketing News

Angela Dunn, Director Social Media, Odom Lewis

There are helpful nuggets throughout. In my opinion, if you have time to only dig into one brief chapter, read what Susannah Fox wrote. Great stuff.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

19 Seconds of Pure Joy

What happens when a 1-year old pup encounters her first serious snow of the season?

Pure joy. For everyone.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

This will be the final Impactiviti Daily for 2009. We’ll pick up again in the new year. Have a delightful holiday season!

TODAY’S NEWS

Deals – J&J and Merck get hits, Biogen strikes out.

From PharmaExec – a new commercialization model needed for pharma? – The days when biopharmaceutical companies could rely upon a steady stream of blockbuster products to fuel sales and support large, fixed-cost infrastructures appear to be over. It is clear that with the issues facing the pharmaceutical industry — coupled with a changing future environment — the current commercial model is too cumbersome to deal with hard economic conditions or to react to new stakeholder environmentsmore

Pfizer and BI get expanded label for Spiriva for COPD – Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). SPIRIVA HandiHaler is already FDA-approved as a once-daily maintenance treatment for breathing problems associated with COPD, which includes chronic bronchitis, emphysema, or bothmore

Cancer genomes revealed – this is pretty cool, actually. A big step toward personalized medicine.

Medical Rep certification – coming soon!

RECOMMENDED

Training and eMarketing. The Impactiviti network has great suppliers for all your training, social media, and eMarketing needs.  We “matchmake” best-in-class vendor/providers with clients’ needs. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

JUST FOR FUN

Business Week gives their visual and descriptive accounting of the 50 ugliest cars of the last 50 years. There are some…umm…beauties in there.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

TODAY’S NEWS

Crestor – now no high cholesterol needed!

Ah, lawyers. NJ, the judicial hellhole. And, the video Pfizer doesn’t want you to see.

Rare diseases and big pharma.

RECOMMENDED

Compliance training. The Impactiviti network has great suppliers for all your corporate compliance needs.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

VaxTrak – Novartis launches a first-version of an iPhone app for tracking your childrens’ vaccinations. I like it.

JUST FOR FUN

15 Stupidest Warning Labels. Some real winners here!

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

Along with many others, I’m of the opinion that the iPhone will prove to be a very powerful tool for health delivery. It’s a welcome sight to see pharma companies begin to experiment with it, and Novartis Vaccines has just released a nifty cool called VaxTrak (iTunes link), to help parents keep track of their kids’ vaccinations.

Have all your vaccination records stuffed away in various places? Can’t keep track of what’s coming next? This may solve the problem.

Here’s the description from the iTunes store:

I’ve downloaded it and begun to play with it. First blush – VaxTrak is nice and simple.  The interface is completely intuitive, and the app works exactly as it should. You enter in the basic info for each family member, and the Planner then generates all the dates for vaccinations (that should have happened in the past, and pending). You can mark all the ones that have occurred, or “opt out.”

The Spot Shots is really cool – basically, it uses geolocation to show you the nearby stores/pharmacies where meds are available.

Now, you can have all those records (and future dates) handy in one spot. And, it’s free. Awesome.

It should be noted that the schedules and geolocation, etc. are currently only for the United States market. Hopefully an updated version will include country-specific info for other areas of the globe.

What I REALLY like about VaxTrak is that this same concept can be adapted for so many other medical “scheduling” needs. This will serve as a great template for a host of similar applications. Simple. Focused. Intuitive.

Kudos to Novartis Vaccines for rolling this out. Very nicely done.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

TODAY’S NEWS

Sanofi - now laying off contract sales reps and some others.

Pfizer and compliance. That’s a lot of corporate integrity agreements (from PharmaGossip blog)

From the NYTimes: Menopause, as brought to you by Big Pharma – MILLIONS of American women in the 1990s were told they could help their bodies ward off major illness by taking menopausal hormone drugs. Some medical associations said so. Many gynecologists and physicians said so. Respected medical journals said so, too…more

RECOMMENDED

Instructional Design. The Impactiviti network has great suppliers for all your Instructional Design needs – ISD professionals to create training, or to help with strategy and design.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Thinking about starting (or marketing) a business? Some lessons I’ve learned over 3.5 years…

JUST FOR FUN

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

TODAY’S NEWS

Bone drugs may help prevent breast cancer? – New results from a landmark women’s health study raise the exciting possibility that bone-building drugs such as Fosamax and Actonel may help prevent breast cancer. Women who already were using these medicines when the study began were about one-third less likely to develop invasive breast cancer over the next seven years than women not taking such pills, doctors reported Thursdaymore

An effort to restrict data mining – An amendment to the Senate health care bill would effectively ban data mining which, as you know, involves the practice of buying prescription records to target sales pitches to doctors, the Associated Press reports. Democrats Herb Kohl of Wisconsin and Dick Durbin of Illinois say their measure will combat “harassing sales practices” and “restrain undue influence” of sales repsmore

Gilead Sciences drug get FDA panel nod – Federal health advisers are recommending the use of an experimental Gilead Sciences drug to treat a form of lung infection. A Food and Drug Administration panel voted 15-2 in favor of the safety and effectiveness of the inhalable drug Cayston. Cayston is intended to treat chronic lung infections in patients with cystic fibrosis — an often fatal disease that affects the lungs and digestive system. Lung infections are the biggest killer of people with the disease. Federal health advisers are recommending the use of an experimental Gilead Sciences drug to treat a form of lung infectionmore

King: nice and careful with Embeda promotion.ASH update from Sally Church over at Pharma Strategy blog (Sally is a smart cookie, by the way). Along with her update on how OIG guidelines have impacted the exhibit hall.

RECOMMENDED

On-line: Learning Management; Assessment Management; Simulations; Reinforcements. The Impactiviti network has great suppliers for all your technology training needs – and Impactiviti can provide needed technology consulting for needs analysis, RFP design, and vendor selection.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Is social media all that big a deal, anyway? Some startling statistics.

JUST FOR FUN

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

Older Posts »

Follow

Get every new post delivered to your Inbox.

Join 27 other followers